Table 1 Demographic and clinical data in patients infected with HCV and occult hepatitis B. Rio de Janeiro, 2018
From: Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients
Categorical variables | N | % |
|---|---|---|
Gender | ||
 Female | 06 | 54.5 |
 Male | 05 | 45.5 |
Fibrosis stage | ||
 F2 | 02 | 18.2 |
 F4 | 09 | 81.8 |
Genotype HCV | ||
 1a | 05 | 45.5 |
 1b | 04 | 36.4 |
 3a | 02 | 18.2 |
Genotype HBV | ||
 A1 | 01 | 9.1 |
 A2 | 02 | 18.2 |
 ND | 08 | 72.7 |
Continuos variables | Mean | SD |
|---|---|---|
Age (years) | 65.64 | 6.89 |
Viral Load (log) | 3.36 | 1.01 |
ALT* | 62.91 | 29.92 |
AST* | 72.09 | 41.95 |
GGT* | 76.64 | 64.02 |
BT* | 0.67 | 0.27 |
Copies/mL—HBV | 1.76E + 07 | 4.56E + 07 |
IU/mL** | 32,851.90 | 80,988.23 |
Continuos variables | Median | P25–75 |
|---|---|---|
Age (years) | 66 | 62–69 |
Viral Load (log) | 3.26 | 2.61–3.71 |
ALT* | 68 | 39–76 |
AST* | 71 | 33–109 |
GGT* | 65 | 38–94 |
BT* | 0.80 | 0.40–0.90 |
Copies/mL—HBV | 1.03E + 04 | 2.26E + 03–8.50E + 04 |
IU/ml** | 1839.5 | 403–5178.1 |